ArticleJournal for immunotherapy of cancer2021

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy.

James McAuliffe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.